Kinomica
1 known investors
Kinomica develops KScan, a phosphoproteomic diagnostic platform that analyzes which proteins and signaling pathways are activated to guide treatment selection for patients and support the discovery of new drug targets. The company focuses on precision medicine and response-to-treatment diagnostics.
BiotechDeep TechDigital Health